BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9531187)

  • 1. Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.
    Torres VE; Bengal RJ; Nickander KK; Grande JP; Low PA
    Am J Kidney Dis; 1998 Apr; 31(4):687-93. PubMed ID: 9531187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
    Cowley BD; Rupp JC; Muessel MJ; Gattone VH
    Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggravation of polycystic kidney disease in Han:SPRD rats by buthionine sulfoximine.
    Torres VE; Bengal RJ; Litwiller RD; Wilson DM
    J Am Soc Nephrol; 1997 Aug; 8(8):1283-91. PubMed ID: 9259355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
    Cowley BD; Ricardo SD; Nagao S; Diamond JR
    Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.
    Aukema HM; Housini I
    Kidney Int; 2001 Jan; 59(1):52-61. PubMed ID: 11135057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats.
    Keith DS; Torres VE; Johnson CM; Holley KE
    Am J Kidney Dis; 1994 Sep; 24(3):491-8. PubMed ID: 8079975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary biomarkers for monitoring disease progression in the Han:SPRD-cy rat model of autosomal-dominant polycystic kidney disease.
    Wiedmeyer CE; Royal AB
    Comp Med; 2010 Dec; 60(6):448-54. PubMed ID: 21262131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-dependent effect of L-NAME on polycystic kidney disease in Han:SPRD rats.
    Yoshida I; Bengal R; Torres VE
    Am J Kidney Dis; 2000 May; 35(5):930-6. PubMed ID: 10793029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats.
    Kränzlin B; Schieren G; Gretz N
    Kidney Int; 1997 Apr; 51(4):1160-9. PubMed ID: 9083282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
    Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
    Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
    Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
    Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saskatoon berry supplementation prevents cardiac remodeling without improving renal disease in an animal model of reno-cardiac syndrome.
    Raj P; Louis XL; Yu L; Siow YL; Suh M; Aukema HM; Netticadan T
    J Food Biochem; 2021 Oct; 45(10):e13893. PubMed ID: 34459008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of disease progression in rats with inherited polycystic kidney disease.
    Cowley BD; Grantham JJ; Muessel MJ; Kraybill AL; Gattone VH
    Am J Kidney Dis; 1996 Jun; 27(6):865-79. PubMed ID: 8651252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dietary flaxseed supplementation on organic anion and osmolyte content and excretion in rat polycystic kidney disease.
    Ogborn MR; Nitschmann E; Bankovic-Calic N; Buist R; Peeling J
    Biochem Cell Biol; 1998; 76(2-3):553-9. PubMed ID: 9923725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cystic disease and ammoniagenesis in Han:SPRD rats.
    Torres VE; Mujwid DK; Wilson DM; Holley KH
    J Am Soc Nephrol; 1994 Nov; 5(5):1193-200. PubMed ID: 7873729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender hormones and the progression of experimental polycystic kidney disease.
    Stringer KD; Komers R; Osman SA; Oyama TT; Lindsley JN; Anderson S
    Kidney Int; 2005 Oct; 68(4):1729-39. PubMed ID: 16164649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.